Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Munawaer Muaibati"'
Autor:
Fanwei Huang, Liang He, Wei Li, Xiaoyuan Huang, Tao Zhang, Munawaer Muaibati, Hu Zhou, Shimin Chen, Wenhui Yang, Fan Yang, Liang Zhuang, Ting Hu
Publikováno v:
Infectious Agents and Cancer, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract Background This study aimed to investigate whether persistent human papillomavirus integration at the same loci (PHISL) before and after treatment can predict recurrent/residual disease in women with CIN2-3. Methods A total of 151 CIN2-3 wom
Externí odkaz:
https://doaj.org/article/310281b570ed45179a2af525e10b8cd5
Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy
Autor:
Qing Tong, Kexin Li, Fanwei Huang, Yun Dai, Tao Zhang, Munawaer Muaibati, Abasi Abuduyilimu, Xiaoyuan Huang
Publikováno v:
Materials Today Bio, Vol 23, Iss , Pp 100845- (2023)
Combination immunotherapy of cancer vaccines with immune checkpoint inhibitors (ICIs) represents a promising therapeutic strategy for immunosuppressed and cold tumors. However, this strategy still faces challenges, including the limited therapeutic e
Externí odkaz:
https://doaj.org/article/5ed7def9ac1940cbae43f509c34aaf90
Autor:
Tao Zhang, Liang Zhuang, Munawaer Muaibati, Dan Wang, Abuduyilimu Abasi, Qing Tong, Ding Ma, Lei Jin, Xiaoyuan Huang
Publikováno v:
EBioMedicine, Vol 92, Iss , Pp 104612- (2023)
Summary: Background: Cervical cancer is the fourth leading cause of mortality among gynecological malignancies. However, the identification of cervical cancer stem cells remains unclear. Methods: We performed single-cell mRNA sequencing on ∼122,400
Externí odkaz:
https://doaj.org/article/f31312c64d2b4513b5d90793cde73a68
Autor:
Munawaer Muaibati, Abasi Abuduyilimu, Tao Zhang, Yun Dai, Ruyuan Li, Fanwei Huang, Kexin Li, Qing Tong, Xiaoyuan Huang, Liang Zhuang
Publikováno v:
Expert Reviews in Molecular Medicine. 25
Ovarian cancer is the most lethal female reproductive system tumour. Despite the great advances in surgery and systemic chemotherapy over the past two decades, almost all patients in stages III and IV relapse and develop resistance to chemotherapy af
Autor:
Kexin Li, Weiming Xie, Abuduyilimu Abasi, Yun Dai, Tao Zhang, Munawaer Muaibati, Liang Zhuang, Qing Tong, Yifan Meng, Xiaoyuan Huang
Publikováno v:
Cancer Investigation. 40:293-309
PurposeThe efficacy of programmed cell death protein 1(PD-1)/Programmed cell death 1 ligand 1 (PD-L1) inhibitors for endometrial cancer remain controversial, and guidelines are unconsistent on which are preferred theropies for advanced disease, or wh